Free Trial

Bright Minds Biosciences (DRUG) News Today

Bright Minds Biosciences logo
$26.11 +2.84 (+12.20%)
As of 06/30/2025 04:00 PM Eastern

DRUG Latest News

Bright Minds Biosciences expands Scientific Advisory Board
Bright Minds Biosciences (DRUG) Receives a New Rating from Piper Sandler
Vascular health doctor in clinical laboratory for medical research and development concepts. and science with a microscope and a test tube placed beside it - stock image
Biotechs on the Brink: 2 Stocks With Huge Potential (DRUG)
BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.
Bright Minds Biosciences initiated with an Overweight at Piper Sandler
Get Bright Minds Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter.

DRUG Media Mentions By Week

DRUG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DRUG
News Sentiment

1.21

0.90

Average
Medical
News Sentiment

DRUG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DRUG Articles
This Week

3

2

DRUG Articles
Average Week

Get Bright Minds Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:DRUG) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners